Agios Pharmaceuticals
AGIO Small CapHealthcare · Biotechnology
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Agios Pharmaceuticals Stock at a Glance
Agios Pharmaceuticals (AGIO) is currently trading at 24,02 € with a market capitalization of 1,4 Mrd. €. The 52-week range spans from 18,97 € to 39,24 €; the current price is 38.8% below the yearly high. Year-over-year revenue growth stands at +137.7%.
💰 Dividendo
Agios Pharmaceuticals currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
8 analysts rate Agios Pharmaceuticals (AGIO) on consensus: Comprare. The average price target is 35,08 €, implying +46.04% from the current price. Analyst price targets range from 23,88 € to 51,18 €.
Tesi di Investimento: Punti di Forza e Debolezze
- Strong revenue growth of 137.7% YoY
- Analyst consensus: Buy
- Solid balance sheet with low debt (D/E 3.22)
- –High short interest (12.17%)
- –Negative free cash flow
Panoramica Tecnica
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, elevated short interest (12.17%).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Agios Pharmaceuticals?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
